Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 467Skin Neoplasms 144Carcinoma, Basal Cell 94Breast Neoplasms 78Neoplasms 68Lymphoma, T-Cell, Cutaneous 62Lung Neoplasms 57Carcinoma, Squamous Cell 40Carcinoma, Non-Small-Cell Lung 40Mycosis Fungoides 39Uveal Melanoma 38Sezary Syndrome 37Lymphoma, Non-Hodgkin 35Lymphoma 35Keratosis, Actinic 35Pancreatic Neoplasms 34Sarcoma 33Prostatic Neoplasms 33Head and Neck Neoplasms 33Colorectal Neoplasms 33Leukemia, Lymphocytic, Chronic, B-Cell 31Ovarian Neoplasms 30Urinary Bladder Neoplasms 29Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Colonic Neoplasms 28Lymphoma, Mantle-Cell 27Lymphoma, Follicular 27Leukemia 27

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Arthritis, Reactive × Dermatologic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡